Skip to main content
. 2021 Mar 16;3(1):48–58. doi: 10.1016/j.jaccao.2020.12.003

Table 2.

Association of CV Risk Factors, Biomarkers, and CVD With Cancer

Cancer (n/N = 2,548/20,305)
HR (95% CI) p Value
CV risk factors
 Age 2.12 (2.00−2.26) <0.001
 Male 1.39 (1.28−1.51) <0.001
 SBP 0.99 (0.94−1.03) 0.49
 HTN treatment 1.10 (1.00−1.22) 0.06
 BMI 1.03 (0.99−1.08) 0.20
 DM 1.10 (0.94−1.30) 0.24
 Former smoker 1.30 (1.18−1.43) <0.001
 Current smoker 1.74 (1.57−1.93) <0.001
 TC/HDL 0.96 (0.91−1.00) 0.048
 Statin use 0.92 (0.77−1.10) 0.36
Risk scores
 10-yr ASCVD risk 1.16 (1.14−1.17) <0.001
 Low Ref.
 Borderline 1.88 (1.63−2.18) <0.001
 Intermediate 2.70 (2.44−3.00) <0.001
 High 3.71 (3.29−4.19) <0.001
Biomarkers
 NP tertile 1 Ref. ptrend = 0.02
 Tertile 2 1.10 (0.90−1.34) 0.35
 Tertile 3 1.40 (1.02−1.91) 0.035
 NP × time interaction 0.87 (0.81−0.95) 0.001
 Continuous 1.26 (1.12−1.41) <0.001
 hs-cTn tertile 1 Ref. ptrend = 0.47
 Tertile 2 1.24 (1.01−1.53) 0.043
 Tertile 3 1.16 (0.84−1.61) 0.37
 hs-cTn × time interaction 0.95 (0.88−1.03) 0.18
 Continuous 1.10 (0.99−1.21) 0.07
Previous events
 CVD, n = 1,020 0.96 (0.82−1.12) 0.61
 MI, n = 793 1.03 (0.87−1.22) 0.71
 HF, n = 116 0.66 (0.37−1.17) 0.15
Interim events
 CVD, n = 1454 0.99 (0.85−1.16) 0.91
 MI, n = 687 0.99 (0.79−1.25) 0.95
 HF, n = 681 1.07 (0.84−1.36) 0.59

CI = confidence interval; CVD = cardiovascular; HF = heart failure; hs-cTn = high-sensitivity cardiac troponin; MI = myocardial infarction; NP = natriuretic peptide; other abbreviation as in Table 1.

Multivariable model adjusts for age, sex, SBP, HTN treatment, BMI, DM, total cholesterol/high-density lipoprotein (TC/HDL), statin use, smoking status. HR (hazards ratio) per dichotomous variable or 1 SD increase in a continuous variable.

Continuous 10-yr ASCVD risk: HR per 5% increase in estimated 10-yr risk. ASCVD categories: HR of ASCVD risk category compared with ASCVD low-risk category.

Time interaction variable is displayed to account for violation of the proportionality hazards assumption,